Table 2. Effects of sch9Δ and rapamycin on V-ATPase assembly and disassembly.
Condition | Fold change | Adjusted P-value |
---|---|---|
Glucose-induced fold decrease a | ||
WT (YPD vs YP) | 1.91 | 0.0063 |
sch9Δ (YPD vs YP) | 1.39 | 0.0072 |
Rapamycin effect on glucose-induced fold decrease a | ||
WT (YPD + R vs YP + R) | 1.70 | 0.0001 |
sch9Δ (YPD + R vs YP + R) | 1.40 | 0.0017 |
Rapamycin-induced fold increase a | ||
WT (YPD vs YPD + R) | 1.50 | 0.0016 |
sch9Δ (YPD vs YPD + R) | 1.10 | ns |
Sch9-induced fold increase b | ||
WT (YPD) vs sch9Δ (YPD) | 1.47 | 0.0122 |
WT (YPD + R) vs sch9Δ (YPD) | 1.02 | ns |
WT (YPD + R) vs sch9Δ (YPD + R) | 0.94 | ns |
a Statistical significance was determined using a paired one-way ANOVA analysis (Holm-Sidak's multiple comparisons test).
b Statistical significance was determined using an unpaired one-way ANOVA analysis (Holm-Sidak's multiple comparisons test).